[(1S,2R,4S,5S,8S,9S,12S,13R,15S,17R,18S)-18-hydroxy-9,13-dimethyl-8-[(2-methylpropan-2-yl)oxy]spiro[16,19-dioxapentacyclo[13.3.1.01,13.04,12.05,9]nonadecane-2,2'-oxirane]-17-yl] 3-chlorobenzoate 、
叔丁基二甲基氯硅烷 在
咪唑 作用下,
以
N,N-二甲基甲酰胺 为溶剂,
以82%的产率得到[(1S,2S,4S,5S,8S,9S,12S,13R,15S,17R,18S)-18-[tert-butyl(dimethyl)silyl]oxy-2-(chloromethyl)-2-hydroxy-9,13-dimethyl-8-[(2-methylpropan-2-yl)oxy]-16,19-dioxapentacyclo[13.3.1.01,13.04,12.05,9]nonadecan-17-yl] 3-chlorobenzoate